Evidence map›Paper›PMID 31234428›Full record

ReviewMedicina (Kaunas, Lithuania)2019

Alterations of Methionine Metabolism as Potential Targets for the Prevention and Therapy of Hepatocellular Carcinoma.

Rosa M Pascale, Graziella Peitta, Maria M Simile, Francesco Feo

Open access · goldAbstract readReview
In one paragraph

Review in Medicina (Kaunas, Lithuania), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. HAntioxidants (Basel, Switzerland) · 2023
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Cysteine as a Multifaceted Player in Kidney, theMolecules (Basel, Switzerland) · 2022
    Review
  17. Review
  18. Article
  19. Article
  20. Regulation of Ferroptosis by Amino Acid Metabolism in Cancer.International journal of biological sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rosa M PascaleDepartment of Clinical, Surgery and Experimental Sciences, Division of Experimental Pathology and Oncology, University of Sassari, 07100 Sassari, Italy. patsper@uniss.it.
Graziella PeittaDepartment of Clinical, Surgery and Experimental Sciences, Division of Experimental Pathology and Oncology, University of Sassari, 07100 Sassari, Italy. graziella.85@live.it.
Maria M SimileDepartment of Clinical, Surgery and Experimental Sciences, Division of Experimental Pathology and Oncology, University of Sassari, 07100 Sassari, Italy. simile@uniss.it.
Francesco FeoDepartment of Clinical, Surgery and Experimental Sciences, Division of Experimental Pathology and Oncology, University of Sassari, 07100 Sassari, Italy. feo@uniss.it.
University of Sassari · IT

Funding

Associazione Italiana per la Ricerca sul Cancro IG13068
6 · The paper itself

Abstract

Several researchers have analyzed the alterations of the methionine cycle associated with liver disease to clarify the pathogenesis of human hepatocellular carcinoma (HCC) and improve the preventive and the therapeutic approaches to this tumor. Different alterations of the methionine cycle leading to a decrease of S-adenosylmethionine (SAM) occur in hepatitis, liver steatosis, liver cirrhosis, and HCC. The reproduction of these changes in MAT1A-KO mice, prone to develop hepatitis and HCC, demonstrates the pathogenetic role of

Indexed as

AnimalsCarcinoma, HepatocellularDisease Models, AnimalGene Expression Regulation, NeoplasticHumansLiverLiver NeoplasmsMethionineMethionine AdenosyltransferaseMiceS-AdenosylmethionineMat1a protein, mouseMat2a protein, mouseMethionineMethionine AdenosyltransferaseS-Adenosylmethioninehepatocarcinogenesismechanisms of action of SAMmethionine metabolismmethyladenosyltransferasesS-adenosylmethioninesignal transduction

Identifiers

PMID31234428
PMCPMC6631235
OpenAlexW2951485607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.